US 8,469,977 B2Grant
Endoscopic plication device and method
Issue Date:2013-06-25
•9 Claims
•37 Drawing Sheets
Abstract
Described herein are endoscopic plicators passed transorally into the stomach and used to plicate stomach tissue by engaging tissue from inside of the stomach and drawing it inwardly. In the disclosed embodiments, the tissue is drawn inwardly into a vacuum chamber, causing sections of serosal tissue on the exterior of the stomach to be positioned facing one another. The disclosed plicators allow the opposed sections of tissue to be moved into contact with one another, and preferably deliver sutures, staples or other means for maintaining contact between the tissue sections at least until serosal bonds form between them. Each of these steps may be performed wholly from the inside of the stomach and thus can eliminate the need for any surgical or laparoscopic intervention. After one or more plications is formed, medical devices may be coupled to the plication(s) for retention within the stomach.
Metadata
Assignee
- Barosense, Inc.
Inventors
- Daniel J. Balbierz
- Dave Cole
- Samuel T. Crews
- Brett Swope
- Andrew Smith
- John Lunsford
- Fiona Sander
Application Information
Application Number:US 12/785,268
Filing Date:2010-05-21
Priority Date:2005-10-03
Art Unit:3773
Classifications
IPC:
A61B17/72
Patent Drawings (37 sheets)
Description
Priority
[0001] This application is a continuation of U.S. patent application Ser. No. 11/542,457, filed on Oct. 3, 2006, now pending, which claims the benefit of U.S. Provisional Application No. 60/723,160, filed Oct. 3, 2005; U.S. Provisional Application No. 60/754,417, filed Dec. 28, 2005; and U.S. Provisional Application No. 60/825,534, filed Sep. 13, 2006, the disclosures of each are incorporated by reference herein.
Field of the Invention
[0002] The present invention relates generally to the field of systems and methods for performing endoscopic surgery, and specifically to systems and methods for endoscopic plication of tissue within body cavities.
Background of the Invention
[0003] An anatomical view of a human stomach S and associated features is shown in FIG. 1A . The esophagus E delivers food from the mouth to the proximal portion of the stomach S. The z-line or gastro-esophageal junction Z is the irregularly-shaped border between the thin tissue of the esophagus and the thicker tissue of the stomach wall. The gastro-esophageal junction region G is the region encompassing the distal portion of the esophagus E, the z-line, and the proximal portion of the stomach S.
[0004] Stomach S includes a fundus F at its proximal end and an antrum A at its distal end. Antrum A feeds into the pylorus P which attaches to the duodenum D, the proximal region of the small intestine. Within the pylorus P is a sphincter that prevents backflow of food from the duodenum D into the stomach. The middle region of the small intestine, positioned distally of the duodenum D, is the jejunum J.
[0005] FIG. 1B illustrates the tissue layers forming the stomach wall. The outermost layer is the serosal layer or “serosa” S and the innermost layer, lining the stomach interior, is the mucosal layer or “mucosa” MUC. The submucosa SM and the multi-layer muscularis M lie between the mucosa and the serosa.
[0006] Several prior applications sharing inventors with the present application, including International Application No. WO 2005/037152 having an international filing date of Oct. 8, 2004 and U.S. application Ser. No. 11/439,461, filed May 23, 2006 (both incorporated herein by reference) describe methods according to which medical implants are coupled to tissue structures formed within the stomach. According to these applications, devices for inducing weight loss (e.g. by restricting and/or obstructing flow of food into the stomach, and/or by occupying a portion of the stomach volume) may be coupled to tissue tunnels or plications P (FIG. 2 ) formed from stomach tissue.
[0007] For example, U.S. application Ser. No. 11/439,461 (incorporated herein by reference in its entirety), describes a restrictive and/or obstructive implant system for inducing weight loss. In one embodiment, flexible loops 2 (FIG. 3 ) are coupled to tissue plications P (FIG. 2 ) formed in the gastroesophageal junction region of the stomach. An implant, such as a flow restrictive and/or obstructive implant 4 (FIG. 4 ), is passed through the loops 2 and thus retained in the stomach as shown in FIG. 5 .
[0008] In other instances, tissue plications may themselves be sufficient to provide the necessary treatment. For example, the plications may be used to reduce stomach volume or form a flow restriction within the stomach.
[0009] Other types of implants may be coupled to such plications or other tissue structures for a variety of purposes. These implants include, but are not limited to prosthetic valves for the treatment of gastro-esophageal reflux disease, gastric stimulators, pH monitors and drug eluting devices that release drugs, biologics or cells into the stomach or elsewhere in the GI tract. Such drug eluting devices might include those which release leptin (a hormone which creates feelings of satiety), Ghrelin (a hormone which creates feelings of hunger), octreotide (which reduces Ghrelin levels and thus reduces hunger), Insulin, chemotherapeutic agents, natural biologics (e.g. growth factor, cytokines) which aid in post surgery trauma, ulcers, lacerations etc. Still other implants might be of a type which might provide a platform to which specific cell types can adhere, grow and provide biologically-active gene products to the GI tract, and/or a platform for radiation sources that can provide a local source of radiation for therapeutic purposes, or provide a platform whereby diagnostic ligands are immobilized and used to sample the GI tract for evidence of specific normal or pathological conditions, or provide an anchor point for imaging the GI tract via cameras and other image collecting devices.
[0010] The prior applications listed above, address the desirability of forming tissue plications, pockets or tunnels in a way that regions of serosal tissue (i.e. the tissue on the exterior surface of the stomach) are retained in contact with one another. Over time, adhesions formed between the opposed serosal layers create strong bonds that can facilitate retention of the plication/pocket/tissue over extended durations, despite the forces imparted on them by stomach movement and implanted devices. More durable plications can be created by placing any of a number of materials and/or substances (i.e. injectable sclerosing agents) between the serosal surfaces prior to plicating the serosal surfaces together. One example of material suitable for this purpose is polypropolyene mesh, commonly used for hernia repair, which when inserted in the plication fold provides a durable anchoring position within the GI tract.
[0011] Regardless of the application for which a plication is being formed, it is highly desirable to form that plication using steps carried out from within the stomach using instruments passed down the esophagus, rather than using more invasive surgical or laparoscopic methods. The present application describes endoscopic plicators which may be passed transorally into the stomach and used to form serosal-to-serosal plications in a stomach wall.
Brief Description of the Drawings
[0012] FIG. 1A is a schematic illustration of a human stomach and a portion of the small intestine.
[0013] FIG. 1B is a cross-sectional perspective view of a portion of a stomach wall, illustrating the layers of tissue forming the wall.
[0014] FIG. 2 schematically illustrates a serosal tissue plication formed in stomach tissue.
[0015] FIG. 3 schematically illustrates a pair of loops attached to serosal tissue plications, prior to the positioning of a medical implant within the loops.
[0016] FIG. 4 is a cross-sectional side elevation view of a satiation implant.
[0017] FIG. 5 schematically illustrates the satiation implant of FIG. 4 coupled to the loops of FIG. 3 .
[0018] FIG. 6 is a perspective view of an endoscopic plication system.
[0019] FIG. 7 is a perspective view of the vacuum head of the system of FIG. 6 .
[0020] FIG. 8A is a side elevation view of the cannula of the system of FIG. 6 .
[0021] FIG. 8B is a perspective view of the distal end of the cannula of FIG. 8A .
[0022] FIG. 9 is a cross-sectional side view of an anchor of the system of FIG. 6 .
[0023] FIG. 10 is a plan view of the catch of the anchor of FIG. 9 .
[0024] FIG. 11A is a plan view of the spring element of the anchor of FIG. 9 .
[0025] FIG. 11B is a perspective view of the spring element of FIG. 11A , showing the spring tabs in the opened position.
[0026] FIG. 12 is a perspective view of the vacuum head of FIG. 7 , showing the anchor of FIG. 9 positioned within the vacuum head.
[0027] FIG. 13 is a perspective view of the anchor of FIG. 9 , which includes a loop of the type shown in FIG. 3 .
[0028] FIG. 14A is a perspective view of the mesh tube of the system of FIG. 6 .
[0029] FIG. 14B is cross-sectional perspective view showing the mesh tube of FIG. 14A in the compressed orientation.
[0030] FIG. 15A is a side elevation view showing the tip, cable, mesh tube, and sheath of FIG. 6 following assembly.
[0031] FIG. 15B is a side elevation view of the plicator of FIG. 6 assembled for use.
[0032] FIG. 16A schematically illustrates introduction of the assembled plicator and an endoscope into the stomach.
[0033] FIG. 16B schematically illustrates creation of a tissue pocket using the plicator of FIG. 16A .
[0034] FIG. 17A is a perspective view of a barbed stabilizing cuff.
[0035] FIG. 17B is a perspective view similar to FIG. 16B , showing use of the barbed stabilizing cuff of FIG. 17A to stabilize tissue within the pocket.
[0036] FIG. 18A schematically illustrates positioning of the tip element and mesh tube following their deployment.
[0037] FIG. 18B schematically illustrates the stomach exterior surface following deployment of the tip and anchor.
[0038] FIG. 19A illustrates compression of the anchor using the plicator and cable.
[0039] FIG. 19B shows the final anchor and mesh position following removal of the plicator and endoscope.
[0040] FIG. 20 illustrates an alternative method for compressing the anchor.
[0041] FIGS. 21A through 21C are perspective views illustrating an alternative vacuum chamber in which the vacuum chamber also forms the implantable anchor.
[0042] FIGS. 22A through 22D are a sequence of steps illustrating an alternative method using a vacuum paddle that additionally functions as an implantable anchor.
[0043] FIGS. 23A through 23B and 24A through 24B are a sequence of steps illustrating an alternative method which forms a serosal tunnel and positions a leg of an anchor within the serosal tunnel. FIGS. 23A and 23B are cross-sectional side views. FIGS. 24A and 24B are perspective views taken from within the stomach.
[0044] FIG. 25A is a perspective view taken from within the stomach illustrating the serosal tunnel formed during the sequence of steps illustrated in FIGS. 23A through 24B .
[0045] FIG. 25B is a cross-section view of the serosal tunnel and anchor shown in FIG. 25A .
[0046] FIG. 25C illustrates placement of two of the anchors of FIGS. 23A-24B within a stomach.
[0047] FIGS. 26A through 26C are cross-sectional side views of a plication system and a stomach wall, illustrating an alternative method in which a sclerosing agent is injected into the serosal pocket prior to advancement of the tip element.
[0048] FIGS. 27A and 27B are cross-section views illustrating a method for sealing sclerosing agent within the serosal pocket using a clamp.
[0049] FIGS. 28 and 29 , in which FIG. 28 is a perspective view and FIG. 29 is a cross-section view of a distal end of a plication system and a portion of the stomach wall, illustrate methods for sealing sclerosing agent within the serosal pocket using the vacuum head.
[0050] FIGS. 30A through 30D are a sequence of side views of a stomach wall engaged by a vacuum chamber, and illustrate steps of an alternative method of forming a tissue plication using sclerosing agents.
[0051] FIGS. 31A and 31B illustrate alternate place holding elements for use in the method of FIGS. 30A-30D .
[0052] FIGS. 32A and 32B illustrate the use of clamps to retain plications formed using the FIG. 30A-30D method during healing of the plications.
[0053] FIG. 33A is a perspective view of a serosal plication having a cutout formed through the tissue. FIG. 33B is a cross-section view of a stomach illustrating three serosal plications of the type shown in FIG. 33A .
[0054] FIG. 34A is a cross-sectional side view of a second preferred embodiment of a plication system.
[0055] FIGS. 34B-34G are a sequence of cross-sectional side views illustrating formation of a plication of the type shown in FIG. 33A using the system of FIG. 34A .
[0056] FIG. 35A is a cross-section side view of the plication formed in accordance with the method of FIGS. 34A-34G .
[0057] FIG. 35B is a cross-sectional plan view taken along the plane designated 35B-35B in FIG. 35A .
[0058] FIG. 36A is a perspective view of the plication head of an alternative embodiment of a plicator, shown in the streamlined positioned for transoral delivery to the stomach. The shroud is not shown to allow clear viewing of the underlying components.
[0059] FIG. 36B is a perspective view similar to FIG. 36A showing the plication head in the expanded position. The shroud is not shown to allow clear viewing of the underlying components.
[0060] FIGS. 37A through 37D are a sequence of cross-sectional perspective views of the plication head of FIGS. 36A and 36B , illustrating a method of using the plication head. The shroud is not shown to allow clear viewing of the underlying components.
[0061] FIG. 38 is a bottom plan view of the plication head of FIGS. 36A-37C with the shroud in place and the hinge members in the expanded position.
[0062] FIG. 39 is a front elevation view of the plication head as positioned in FIG. 38 .
[0063] FIG. 40A is a cross-sectional side views of the hydraulic chamber a piston assembly used for expanding the vacuum chamber, compressing tissue, and driving the staples in the embodiment of FIGS. 36A-39 .
[0064] FIG. 40B is a cross-sectional side view of the staple driver of the embodiment of FIGS. 36A-37D .
[0065] FIGS. 41A and 41B are side elevation views of a modified plication head with the shroud not shown to permit the underlying components to be seen.
[0066] FIG. 41C is a perspective view of the plication head of FIGS. 41A and 41B , with the shroud shown.
[0067] FIG. 42A is a perspective view of an expandable frame for deploying a reinforcing element. FIG. 42B shows a reinforcing element on the frame of FIG. 42A .
[0068] FIGS. 43A and 43B are plan views illustrating staple patterns.
[0069] FIGS. 43C-43E are plan views illustrating interlocking staple patterns.
[0070] FIGS. 44A and 44B are plan views of reinforcing rings.
[0071] FIG. 45A is a perspective view showing the reinforcing ring of FIG. 44B on a stapler anvil.
[0072] FIG. 45B is a plan view of the reinforcing ring of FIG. 44A on a staple cartridge.
[0073] FIGS. 46A and 46B are plan views of a tissue plication, in which FIG. 46A shows the side of the plication positioned on the staple cartridge side of the plicator, and FIG. 46B shows the side of the plication position on the anvil side of the plicator.
[0074] FIG. 47A is a cross-sectional top view of a stomach, illustrating movement of cutout plications into alignment in preparation for insertion of an implant through their cutouts.
[0075] FIG. 47B is a cross-sectional side view of a stomach, illustrating the alignment step of FIG. 47A .
[0076] FIG. 47C is a cross-sectional side view similar to FIG. 47B , with the implant in place within the cutouts.
[0077] FIG. 48A is a cross-sectional top view of a stomach illustrating an arrangement of cutout plications.
[0078] FIG. 48B is a cross-sectional top view similar to FIG. 48A , showing the cutout plications drawn into alignment with one another.
[0079] FIG. 48C is a cross-sectional top view similar to FIG. 48B , showing an implant positioned in the aligned cutouts of the plications.
[0080] FIG. 48D is a cross-sectional side view of the stomach, illustrating the formation of a food passage in the stomach using the arrangement of plications and the implant shown in FIG. 48C .
[0081] FIG. 49 is a perspective view of a restrictive implant having buttons insertable through holes formed in stomach tissue plications.
Detailed Description
[0082] The present application describes endoscopic plicators which may be passed transorally into the stomach and used to plicate stomach tissue by engaging tissue from inside of the stomach and drawing it inwardly. In the disclosed embodiments, the tissue is drawn inwardly into a vacuum chamber, although tissue may be drawn inwardly using other components that do not involve the use of a vacuum. When a portion the stomach wall is drawn inwardly, sections of serosal tissue on the exterior of the stomach are positioned facing one another. The disclosed plicators allow the opposed sections of tissue to be moved into contact with one another, and preferably deliver sutures, staples or other means for maintaining contact between the tissue sections at least until serosal bonds form between them. Each of these steps may be performed wholly from the inside of the stomach and thus can eliminate the need for any surgical or laparoscopic intervention. After one or more plications is formed, medical devices (including, but not limited to any of the types listed above) may be coupled to the plication(s) for retention within the stomach.
[0083] Certain of the disclosed plicators pass a mesh element and/or a quantity of sclerosing agent through the stomach wall such that it is disposed between the opposed regions of serosal tissue thus enhancing serosal bonding. Some embodiments include a feature that forms a hole in a plication using the plication device, so that a portion of a medical implant may be passed through or linked to the hole the plications. Others of the embodiments are configured to couple an anchor to the plication as it is formed, so that a medical implant may later be coupled to the anchor.
[0084] While this application describes plication systems and methods with respect to the formation of plications in stomach tissue, the embodiments described herein have equal applicability for forming plications in parts of the body outside the GI system.
Plication System of the First Preferred Embodiment
[0085] FIG. 6 illustrates one embodiment of a system 10 for tissue plication that is suitable for endoscopic use, as well as surgical or laparoscopic use if desired.
[0086] Generally speaking, system 10 includes a plicator 12 having a vacuum head 14 and a shaft 16. The system further includes a flexible anchor 18 for attachment to stomach tissue, a tissue penetrating tip element 20 having a cable 22, a mesh element 24, and a sheath 26.
[0087] Referring to FIG. 7 , vacuum head 14 defines a vacuum chamber 28 having an opening that, during use, is positioned into contact with stomach tissue so as to draw the tissue into the chamber 28. Vacuum head 14 further includes slots 32, 34 sized to receive portions of the anchor 18 as described below. The distal and proximal ends of the vacuum head 14 include U-shaped openings 36, 38.
[0088] Referring once again to FIG. 6 , shaft 16 is a flexible elongate member extending from the proximal end of the vacuum head 14. Shaft 16 is equipped with pull-wires (not shown) and/or alternative means for articulating the vacuum head 14 as needed for proper positioning within the stomach. Shaft 16 includes a distal portion 40 having a generally U-shaped slot 42 corresponding to the U-shaped opening 38 in the vacuum head. The proximal portion 46 of shaft 16 is tubular and includes at least one lumen 48 extending its length.
[0089] A tubular cannula 50 extends through the shaft 16 as shown in FIG. 6 . Cannula 50 is fluidly coupled to a source of negative pressure such as a syringe or vacuum pump. Application of suction to the cannula 50 creates a vacuum in the vacuum chamber as discussed in detail below. As most clearly visible in FIGS. 8A and 8B , cannula 50 includes an annular flange 53 (FIGS. 8A and 8B ) surrounding its distal end. A plurality of proximally-oriented ratcheting elements 51 (FIG. 8B ) are positioned within the lumen of cannula 50, adjacent to the cannula's distal end.
[0090] Anchor 18 includes a distal tab 52 and a proximal tab 54 on opposite ends of a central portion 56. Anchor 18 is a flexible element formed of silicone or other flexible, biocompatible material. Its properties permit it to be deformed into the orientation shown in FIG. 9 for insertion into the vacuum head. More specifically, the anchor 18 is positionable within the vacuum head 14 as shown in FIG. 12 with the distal tab 52 disposed in distal slot 32 and the proximal tab 54 within proximal slot 34.
[0091] As best seen in the cross-section view of FIG. 9 , a catch 58 is seated within a recess in the distal tab 52 of anchor 18. Catch 58 may be formed of a resilient material such as stainless steel, nitinol, or resilient polymer that has been over-molded using rubber. As will described in detail below, catch 58 functions to engage a portion of the tip element 20 (FIG. 6 ) after it has been advanced through the tissue undergoing plication. In the illustrated embodiment, catch 58 includes a cutout 60 proportioned to engage the tip 20, however any alternative configuration for the cutout 60 and tip 20 that will permit engagement of the two is equally suitable. A rubber protrusion 62 is positioned on the anchor 14 to receive the sharp tip of the tip element to prevent injury to surrounding tissue.
[0092] Referring again to FIG. 9 , proximal tab 54 includes an opening 64 within which a spring element 66 is positioned. Materials used for the spring element may be similar to those used for the catch 58. Spring element functions to engage cable 22 to retain the anchor in position, and it should be appreciated that alternative features that can perform this function can instead be used. As best shown in FIG. 11A , a preferred spring element 66 includes a pair of tabs 68 that can be pushed to a slightly outward orientation (see FIG. 11B ) when acted upon by a force shown by arrow A in FIG. 9 , but that will return to the closed orientation when the force is relieved. Tabs 60, in their closed orientation, define a central cutout 70.
[0093] It is appropriate to note that anchor 18 may take many alternate forms without departing from the scope of the invention. For example, in one alternative embodiment shown in FIG. 13 , anchor 18a includes a loop 2 of the type described in connection with FIGS. 2-5 coupled to its distal end.
[0094] Referring again to FIG. 6 , tip element 20 includes a piercing element that is sufficiently sharp to penetrate abdominal wall tissue when subjected to an appropriate amount of force. The tip element 20 may be formed of stainless steel or any other material suitable for this purpose. A preferred tip element includes a collar 73 which defines a recess 72 between the distal edge of the collar and the proximal edge of the tip. Recess 72 is proportioned to seat within the cutout 60 (FIG. 10 ) of the anchor's distal catch 58 when the tip element is passed through the cutout 60.
[0095] Cable 22 is coupled to the proximal portion of the tip element 20. Cable 22 preferably includes a series of barbs 74, teeth, or other engagement elements. As will be described in connection with FIG. 19A , during use the cable is engaged by spring element 66 which allows the cable to slide in a proximal direction but that prevents movement of the cable in a distal direction. In other words, the cable functions in a manner similar to a cable tie found in hardware stores.
[0096] As discussed, the system is preferably designed to pass material between the serosal tissue layers so as to faciliate serosal tissue bonding. The material may be a synthetic or non-synthetic mesh (formed of nitinol or other material), porous or non-porous material, slotted material, or any other material through which adhesions will form or onto which tissue will grow. Examples include, but are not limited to, polypropylene, materials sold under the trade names Goretex or Dacron, or tissue graft material such as the Surgisis material sold by Wilson Cook Medical, Inc. The material may be treated with tissue-ingrowth promoting substances such as biologics.
[0097] The delivered material can be constructed into any shape or configuration that will achieve its purpose of promoting strong serosal adhesions. As illustrated in FIGS. 14A and 14B , a convenient form for the delivered material is that of a mesh tube 24 designed such that application of compressive forces between the proximal and distal ends will cause the mesh to take the form of a disk, or such that it will self-expand to a disk-like shape when released from a restrained position. Tubular caps 76a, 76b formed of a suitable polymeric material may be attached to the distal and proximal ends of the tube to minimize damage to the mesh during compression.
Exemplary Method of Using the First Preferred Embodiment
[0098] One method of using the system of FIG. 6 will next be described.
[0099] In preparation for use, tip 20, cable 22, mesh element 24, and sheath 26 are assembled for insertion into cannula 50. Specifically, as shown in FIG. 15A , mesh tube 24 is threaded over cable 22 and positioned such that its distal cap 76b abuts the collar 73 of tip 20. Sheath 26 is positioned over the mesh tube 24 and advanced such that its distal end is also in contact with the collar 73.
[0100] Referring to FIG. 15B , the assembled tip, cable, mesh element and sheath are inserted into the cannula 50. Anchor 18 is seated within the vacuum chamber 28 as described above. The flange 53 of the cannula 50 is positioned in sealing contact with the anchor 18. For example, the flange 53 may be inserted into the proximal opening 64 (FIG. 9 ) of the anchor so as to create an interference fit between the two. Adequate sealing is desirable to prevent loss of vacuum pressure from the vacuum chamber 28 during use.
[0101] Next, the assembled plicator 12 is passed into the stomach S via the esophagus as shown in FIG. 16A . An endoscope 80 is also passed into the stomach to provide visualization of the procedure. Although the endoscope 80 is shown as a separate component, the plicator 12 may be modified to include an integrated endoscope.
[0102] Referring to FIG. 16B , the plicator 12 is advanced to a target location at which a plication is to be formed. The plicator is manipulated using pull wires or other steering elements to place vacuum chamber 28 against the stomach tissue. Suction is applied to the vacuum chamber 28 via cannula 50, thus drawing stomach tissue into the vacuum chamber as shown. Consequently, a pocket 100 forms in the tissue such that if the stomach were to be viewed from the outside a depression in the stomach wall would be visible. Suction is maintained to stabilize the tissue within the vacuum chamber. If additional stabilization of the tissue is desired, the plicator 12 may be provided with a barbed stabilization cuff 82 of the type shown in FIG. 17A . Cuff 82 includes a plurality of barbs 84 oriented to penetrate stomach tissue as shown in FIG. 17B when the tissue is drawn into the chamber 28, thus holding the proximal portion of the captured tissue in place during advancement of the tip member 20 and mesh 24 element. Other stabilizing mechanisms may alternatively be used in lieu of, or in addition to, the cuff and barbs.
[0103] At this point, the tissue is ready for advancement of the tip member 20 through the tissue, as well as deployment of the mesh tube 24 into the pocket 100. Advancement of the tip and deployment of the mesh may be performed in a single step, or they may be formed as a sequence of steps. For simultaneous advancement and deployment, sheath 26 is advanced in a distal direction, thereby driving the tip 20 distally through the tissue walls 102 defining the pocket 100. If the forces of friction between the tubular mesh element 24 and the sheath 26 are sufficiently large, the advancing sheath carries the mesh tube 24 into the pocket. Alternatively, a pushing mandrel 86 (shown in FIG. 17B ) may be advanced distally against the proximal cap 76a of the mesh element 24 to advance the mesh element 24 into the pocket 100. If separate advancement of the tip member 20 and deployment of the mesh element 24 is preferred, the tip member 20 is first driven in a distal direction by distal movement of the sheath 26, and the mesh element is then separately pushed over the cable 22 using the mandrel 86.
[0104] Many alternative structures useful for separately or simultaneously applying pushing forces to the tip element 20 and the mesh element 24 are readily conceivable and may also be used.
[0105] Regardless of the mode of deployment, as the tip member 20 is advanced, its pointed distal end moves into contact with the spring element 66 on the anchor 18, causing tabs 68 (FIGS. 9 , 11A and 11B) to push distally into the position shown in FIG. 11B , and to then return to their substantially planar orientation (FIG. 11B ) once the tip member 20 has cleared the spring element 66. The tip element 20 then passes through the walls 102 of tissue and into engagement with the distal catch 58 of the anchor 18 (i.e. the edges of the cutout 60 seat within recess 72 of the tip element 20), thereby locking the tip element to the catch 58. The distal-most portion of the tip element 20 embeds within the protrusion 62 of the anchor.
[0106] The cable 22 remains attached to the tip element 20 and thus extends through the walls 102, through catch 58 and spring element 66, and through the cannula 50. The mesh tube 24 remains disposed around the cable 22. FIG. 18A is a cross-section view of the stomach illustrating the arrangement of the components after the tip element 20 and mesh tube 24 have been deployed. FIG. 18B shows the outside of the stomach at this stage of the procedure.
[0107] The next series of steps are geared towards drawing the distal and proximal tabs 52, 54 of the anchor 18 towards one another, so as to enclose the mesh element 24 within the pocket 100. Referring to FIG. 19A , the vacuum head 14 is moved in a lateral direction until it separates from the anchor 18 and the pocket 100. (If a barbed stabilization cuff 82 of the type shown in FIG. 17A has been used to engage the tissue, the cuff is first rotated to “unscrew” its barbs from the tissue. This might be achieved, for example, using a rotatable element (not show) that may be grasped and rotated by the user.) Vacuum head 14 is then positioned against the anchor 18 and used to impart a distally-oriented force against the proximal side of the anchor 18. At the same time, fraction is applied to cable 22 so as to impart proximally directed forces to the distal end of the anchor. Ratcheting elements 51 in the cannula 50 prevent the cable 22 from sliding distally in the event that traction of the cable 22 is momentarily released.
[0108] The opposed forces between cable 22 and vacuum head 14 result in compression of the anchor 18 and the mesh tube 24 into the illustrated positions. As the cable 22 tightened, the spring element 66 of the anchor sequentially engages barbs on the cable 22. Once tension on cable 22 is released, the spring element 66 remains engaged with the adjacent barb on the cable so as to retain the anchor in the compressed position. Finally, the cable 22 is clipped, and the plicator 12 is withdrawn from the body, leaving the anchor 18 and mesh positioned as shown in FIG. 19B . The procedure may be repeated to form multiple plications if needed. Following formation of the plication(s), a medical implant may be coupled to the anchor(s) 18 during the course of the same procedure or during a later procedure scheduled to permit sufficient formation of adhesions between the serosal tissue layers 102 to support the implant.
[0109] It should be noted with reference to FIG. 20 that in an alternative method, the cannula 50 may remain coupled to the anchor 18 during lateral movement of the vacuum head 14, causing the proximal portion 40 of the shaft 16 to separate from the cannula 50. According to this embodiment, the anchor 18 may be compressed by pressing the cannula 50 downwardly against the anchor 18 while applying tension to the cable 22. Once the anchor has been secured as described with respect to FIGS. 19A and 19B , the cannula 50 is detached from the anchor 18 and withdrawn from the body.
Alternatives to the First Embodiments
[0110] One alternative system illustrated in FIGS. 21A through 21C is similar to the first preferred embodiment, but differs in that the vacuum head 14e is formed of a compliant material such as silicone and also functions as the anchoring device. During use of the vacuum head 14e, suction is applied to draw tissue into the vacuum head, and a cable 22e (or suture, etc) is passed through the compliant silicone material to form the tissue plication. If necessary, a removable rigid housing 98 may be positioned around the vacuum head to prevent it from collapsing during application of suction.
[0111] In another alternative system shown in FIGS. 22A through 22D , a flexible vacuum paddle 110 is positionable into contact with stomach tissue. In this embodiment, paddle 110 also serves as the anchor that will remain coupled to the tissue.
[0112] Paddle 110 includes an elongate tube 112 that extends through the esophagus and is connectable to a vacuum source 114 positioned outside the body. Paddle 110 is formed of silicone or other flexible material suitable for long term implantation. Loop 2 is integrally coupled to the paddle. An elongate spine 116 is positionable against the paddle 110, and may include elements for temporarily engaging the paddle 110. Spine 116 includes pull wires or other features that may be manipulated from outside the body to deflect it and the adjacent paddle 110 into nested curved positions as shown in FIG. 22B , thus creating a pocket 100 in the tissue. A tip 120 coupled to a cable 122 may be advanced through the elongate tube 112 such that it penetrates the tissue lining the pocket 100 and advances into a portion of the paddle 110, where it is engaged by a catch (e.g. see catch 58 of FIG. 8A ). A mesh element 124 may be advanced over the cable 122 as shown in FIG. 22C , and the cable 122 may be cinched to form the plication using techniques such as those described above, leaving the paddle 110 and loop 2 in place.
[0113] An alternative system illustrated in FIGS. 23A and 23B is similar to the system of the first embodiment of FIG. 6 . Specifically, system 10f includes a vacuum head 14f mounted at the distal end of a shaft 16f of sufficient length to permit the vacuum head 14f to be positioned within the stomach while the proximal portion of the shaft 16f remains outside the oral cavity. The vacuum head is coupled to a source of suction, such as a syringe or vacuum pump.
[0114] A flexible anchor 18f is seated within vacuum head 14f prior to use, similar to the positioning of the anchor 18 of the first embodiment shown in FIG. 12 . The anchor 18f includes a distal tab 52f and a proximal tab 54f having corresponding openings longitudinally aligned with the lumen 48f of the shaft 16f. The system differs from the first embodiment in that the anchor 18f further includes an elongate leg 22f that is coupled to the tabs 52f, 54f during assembly to form the anchor 18f into a loop. Leg 22f includes a tip 20f and a catch 21f positioned to engage the distal tab 52f and the proximal tab 54, respectively. The leg 22f may be manufactured of a flexible polymeric material such as silicon, or it could be formed of a mesh, braid, stent into which surrounding tissue will grow. However, the tip 20f should be capable of penetrating stomach wall tissue.
[0115] Prior to use, the leg 22f is positioned within the lumen 48f of shaft 16f. During implantation of the anchor 18f, serosal tissue is drawn into the vacuum head 14f as shown in FIG. 23A . The leg 22f is advanced through the tabs 52f, 54f, and the sections of stomach wall lying between the tabs, using a push rod (not shown) or other pushing mechanism as described above. The tip 20f engages with distal tab 52f and the catch 21a is restrained by proximal tab 54f. The vacuum head 14f is subsequently removed, leaving the anchor and leg forming a loop surrounding a portion of the stomach wall as shown in FIG. 23B .
[0116] Although the method of implanting the anchor 18f may end with the anchor 18f positioned as shown in FIG. 23B , it is preferable to bring some of the serosal tissue surfaces surrounding pocket 100 into contact with one another so as to trigger growth of serosal bonds between the contacting tissues surfaces, as described before. Methods for cinching the tissue to form a serosal plication are described above and may be modified for use with the FIGS. 23A-23B method. Alternatively, elongate regions of tissue on opposite sides of the leg 22f may be brought into contact with one another and clamped, stapled and or otherwise held in contact to turn the pocket 100 into a sealed serosal pocket 100f surrounding the leg 22f and isolated from the sterile environment outside the stomach. For example, as shown in FIG. 24A , a jaw-type stapling instrument 92 having a vacuum housing 93 may be endoscopically introduced into the stomach and positioned with the jaws 94a, 94b contacting mucosal tissue on opposite sides of the leg 22f. This instrument may be separate from the instrument used to couple the anchor 18f to the tissue, or the instrument of FIG. 23A may be modified to include the stapler jaws 94a, 94b.
[0117] The jaws are clamped as shown in FIG. 24B to bring the serosal tissue surfaces together, and staples are passed through the tissue using the jaws, enclosing the pocket 100 in the tissue and helping to retain the anchor using the re-shaped stomach tissue. After the instrument 92 is removed from the stomach, the serosal tissue surfaces remain held in contact by one or more staple lines 95 (FIGS. 25A and 25B ). The staple lines 95 seal the pocket 100f and reduce the chance of infection by forming a barrier preventing gastric contents that might enter the pocket 100f from moving into the extra-gastric space. Adhesions will then form between the serosal tissue surfaces as described above. To optimize the strength of the adhesions, the leg 22f may include ingrowth-promoting features. For example, leg 22f may be configured to support macro-level ingrowth using a mesh design, or it may include micro-ingrowth promoting features such as a porous surface. Leg 22f might alternatively or additional have a surface coated or impregnated with sclerosing agents. Multiple anchors 18f may be implanted using this method, as shown in FIG. 25C .
[0118] In alternate plication methods, one or more sclerosing agents may be used in conjunction with or in lieu of the mesh element 24. Examples of sclerosing agents include but are not limited to Sodium Tetradecyl Sulfate (STS), Poliodocanol, Chromated Glycerin, Hypertonic saline, Sodium Morrhuate, Sclerodex (hypertonic saline in combination with Dextrose). Other substances that may be positioned with or in place of the mesh element 24 include methylmethacrylate, glues, adhesives, and biorubbers. These may be injected at the time of mesh placement or loaded into the mesh itself and eluded out over a period of time.
[0119] FIGS. 26A through 26F illustrates an alternative method in which a cannula 50a having a tissue-penetrating distal end is passed into the tissue pocket 100 for delivery of an agent. According to the alternative method, tissue pocket 100 is formed using methods similar to those described above. Cannula 50a is advanced through the shaft 16a of the plicator 12a, through anchor 18a and tissue 102, and into the pocket 100. The desired agent is passed through the cannula 50a and into the pocket.
[0120] Once the agent is administered, steps similar to those described above may be performed to form the plication and to attach anchor 18a to the plication. Tip 20a (FIG. 26B ) is thus advanced through the cannula 50a (or through a separate cannula introduced upon removal of the cannula) and advanced as described in connection with the first embodiment. If a mesh element 24a is to be introduced, it may be positioned around the cable 22a as described previously. A pusher tube 86a may be threaded over the cable 22a, through the interior of the mesh tube 24a, and into contact with proximal cap 76a on the mesh element 86a. Sliding the pusher tube 86a distally drives the tip 20a through the plication and into engagement with a distal catch 58a on the anchor, as also advances the mesh element 24a into the pocket 100. In a final sequence of steps, the plication may be “cinched” using methods similar to those described above.
[0121] In certain instances, it might be desirable to completely close the serosal pocket 100 to avoid leakage of injected agents into the peritoneal cavity. The pocket 100 may be sealed using an elongate clamp 90 endoscopically introduced into the stomach and clamped over the tissue pocket to press the serosal surfaces into contact with one another as shown in FIGS. 27A and 27B . Alternatively, vacuum head 14c (FIG. 28 ) may include clamping bars 92, such as elongate rods or inflatable balloons, that are positioned on opposite sides of the pocket to clamp the pocket 100 between them. As yet another alternative, the vacuum head 14d may be biased or hinged to clamp the pocket 100 as shown in FIG. 29 .
[0122] An alternative method for forming plications using sclerosing agents to accelerate scar formation is illustrated in FIGS. 30A through 30E . This method is advantageous in that it allows plications to be formed without the use of sutures or cables, and thus can simplify the procedure.
[0123] As with previous methods, a pocket 100 or depression is formed on the serosal surface by drawing a portion of the stomach wall inwardly using a vacuum head 14f or other device introduced transorally into the stomach. A delivery member 130 is next introduced into the stomach. The delivery member 130 is an elongate tubular device having a lumen through which a sclerosing agent may be delivered, as well as a delivery means for delivering a place holding element 132 into the pocket 100. The delivery member 130 preferably includes a sharpened distal tip capable of penetrating the stomach wall.
[0124] As shown in FIG. 30B , the delivery member 130 is advanced through at least one portion of the stomach wall 102, and used to deliver the place holding element 132 into the pocket 100. The place holding element 102 functions to maintain separation between opposed serosal walls 102, so that the volume between the walls can be filled by a sclerosing agent introduced by the delivery member 130 or a separate delivery method.
[0125] In one embodiment, the place holding element 132 may be delivered by pushing it through the lumen of the delivery member using a pushing mandrel. The place holding element might be a section of material that has a compact size and shape for delivery by the delivery member 130, but that expands upon delivery into the pocket 100. To give a few examples, the element may be formed of a structure having mechanical properties (e.g. sponge or nitinol mesh) that cause it to self-expand when released from the delivery member, or it may be an inflatable balloon tethered to an inflation lumen in the delivery member, or it may be a swellable hydrogel that will increase in volume once exposed to fluid within the pocket (e.g. the sclerosing agent or other fluid injected into the body, and/or fluids present in the peritoneal cavity). In alternate embodiments the place holding element might be delivered directly to the outside of the stomach using laparoscopic methods.
[0126] The element may be formed of a permanent or semi-permanent material (such as the examples described in connection with mesh element 24 above), that will reinforce the plication and/or work together with the sclerosing agent to promote scar formation. Alternatively, the element may be one that is biodegradable or bioabsorbable over a period of time.
[0127] Once the place holding element 132 has been positioned, the vacuum head 14f or a separate clamping device is utilized to clamp and seal the pocket 100 as shown in FIG. 30C (see, for example, the sealing methods described above). Sclerosing agent is injected through the delivery member 130 into the pocket 100. Referring to FIG. 31A , if the place holding element is an inflatable balloon 132a or another type of element that can seal against the tissue forming the pocket, it may be acceptable to eliminate the step of applying sealing forces to the pocket. Referring to FIG. 31B , use of a sponge 132b in lieu of balloon 132a may minimize migration of sclerosing agent out of the cavity. The sponge 132b may be filled with sclerosing agent prior to its delivery into the pocket 100, or it may instead absorb agent introduced into the pocket.
[0128] Sealing forces continue to be applied to the pocket 100 until ample scar tissue has formed within the pocket to maintain the P. Once adequate scar tissue has been formed, sealing forces may be released and the vacuum head removed from the stomach. If the balloon of FIG. 31A is used in lieu of sealing forces, inflation of the balloon is maintained until the sclerosing agent has formed an adequate amount of scar tissue.
[0129] It should be noted with reference to FIGS. 32A and 32B that if sealing forces are needed over an extended during (i.e. to ensure sufficient tissue scarring to retain the plication), a clip 134a may be clipped around the plication to maintain the plication until sufficient scarring has occurred. If needed to prevent unwanted detachment of the clip, an alternative clip 134b (FIG. 31B ) may include prongs positioned to pass through the tissue.
Plication System of the Second Preferred Embodiment
[0130] In many instances it may be desirable to form serosal tissue plications of the type shown in FIG. 33A , which include a cutout C or hole formed through the plication P. As shown in FIG. 33B , multiple such plications may be formed within the stomach to provide a platform for mounting an intragastric device or for other purposes that will be described below.
[0131] When a cutout plication is formed, it may be beneficial to form a seal around the cutout C using staples, sutures or adhesives etc so as to prevent food material and/or gastric juices from passing between the opposed layers of serosal tissue where they can potentially cause infection between the tissue layers or within the extra gastric space. In the FIG. 33A example, a circular array of staples is placed in the tissue surrounding the cutout C for this purpose. Sealing the cutout using staples provides the additional benefit of controlling the bleeding that will occur along the edges of the cutout. In forming the plication P, reinforcing mesh or other suitable material may be positioned between the opposed serosal layers so as to achieve the benefits discussed in connection with the first embodiment.
[0132] A second preferred embodiment of a plication system 10g, shown in cross-section FIG. 34A , is particularly useful for forming a serosal plication having a cutout surrounded by a staple line, and also for positioning a reinforcing mesh element within the plication.
[0133] In general, system 10g includes a plicator 12g comprising a vacuum head 14g having a vacuum chamber 28g and a shaft 16g defining a lumen 48g. A port 49 is fluidly coupled to the vacuum chamber 28g and is connectable to an extracorporeal source of suction (e.g. a syringe or a vacuum pump).
[0134] An elongate staple driver 150 is longitudinally moveable within the lumen 48g. Staple driver may take the form of an elongate tube having a broadened annular head 152 positioned within the vacuum head 14g. A plurality of staples 154 is arranged adjacent to the staple head, preferably in a circular arrangement, but alternative arrangements are equally suitable. A circular anvil 156 is positioned within the vacuum head 14g opposite the staples. Staple driver head 152 is moveable in a distal direction to advance the staples across the vacuum chamber and into contact with the anvil 156.
[0135] The system includes a tubular cannula 50g for forming the cutout C in the tissue. Cannula 50g extends through the lumen of the staple driver 150, with its tissue-penetrating distal end oriented towards the vacuum chamber 28g. Cannula 50g may be advanced in a distal direction to extend through the vacuum chamber 28g and into a tubular channel 158 formed in the distalmost section of the vacuum head.
[0136] An elongate rod 160 having a pointed distal barb or tip 20g extends through the lumen of the cannula 50g. Tubular mesh element 24g surrounds a portion of the exterior surface of rod 160, with its distal end adjacent to the proximal end of tip 20g. Mesh element 24g is preferably a self-expandable tubular element of the type described in connection with FIGS. 14A and 14B . When positioned on the rod 160, the mesh element is compressed to a reduced-diameter position and retained in the compressed position using a retention sleeve 162. A tubular support 164 may be positioned on the rod 160 in abutment with the proximal end of the mesh element 24g.
[0137] System 10g further includes a proximal handle (not shown) that remains outside the body during use of the system. The handle includes actuators, pull wires, push rods, or equivalent components that facilitate longitudinal advancement and withdrawal of the tip 20g, cannula 50g, retention sleeve 162, and staple driver 150, as well as deflection or articulation of the components, as needed to carry out the method for using the system described in the following section.
Exemplary Method for Using the Second Preferred Embodiment
[0138] A method for using the system of the second embodiment will next be described. First, the vacuum head 14g is introduced into a stomach and endoscopically positioned with the vacuum chamber facing the interior surface of the stomach wall. This step is similar to the step illustrated in FIGS. 16A-16B in connection with the first embodiment.
[0139] Suction is applied to the vacuum head 14g via port 49 to draw a portion of the stomach wall into the chamber as shown in FIG. 34B , thus orienting sections S1, S2 of the stomach wall with their serosal surfaces generally facing one another.
[0140] Next, the rod 160 is advanced to drive tip 20g through the sections S1, S2. Tip 20g is captured within the channel 158 adjacent to anvil 156. The mesh element 24g is carried by the rod 160 into position between the stomach wall sections S1, S2. The retention sleeve 162 is retracted, allowing the mesh element 24g to expand to the position shown in FIG. 34D . One or more centering struts 166 extend between the mesh element 24g and rod 160 and maintain the mesh element in a generally centered orientation relative to the rod 160.
[0141] After the mesh element 24g is deployed, the tissue is compressed to the position shown in FIG. 34E to bring the opposed sections S1, S2 of the stomach wall into contact or close proximity with one another and to compress the mesh element 24g into a disk shape (also see FIG. 14B ). This folding/compressing step may be accomplished by folding the vacuum chamber 14g itself, such as by pushing the shaft 16g in a distal direction while maintaining traction on the rod 160. After folding, the staple driver head 152 is pushed distally, driving the staples 154 through the tissue and against the anvil 156 as shown in FIG. 34F . In a simultaneous or separate step illustrated in FIG. 34G , the cannula 50g is advanced to core the tissue, thus forming the cutout C and snipping the centering struts 166 (not visible in FIG. 34G ) connecting the mesh element to the rod 160. In forming the cutout C, the cannula 50g removes a margin of tissue surrounding the punctures created by tip 20g during its advancement towards channel 158.
[0142] The cannula 50g and tip 20g are withdrawn into shaft 16f, and the vacuum head 14g is separated from the tissue, leaving the cutout reinforced plication as shown in FIGS. 35A and 35B .
Plication System of the Third Preferred Embodiment
[0143] A third embodiment of a plicator 200 is shown in FIGS. 36A through 39 . Plicator 200 includes a plication head 202 positioned on the distal end of an elongate shaft 204. As with prior embodiments, shaft 204 is of sufficient length to allow passage of the plication head 202 through the mouth and esophagus into the stomach, while the proximal end of the shaft remains outside the body. A vacuum source 206 is fluidly coupled to the proximal end of the shaft 202. Pullwires 208 extend through the shaft 204 from a handle (not shown) in the proximal end of the shaft and are anchored to a more distal location within the shaft 204, so that manipulation of the pullwires by a user allows for steering/deflection of the plication head 202. Shaft 204 may be formed of a plurality of spine members that articulate relative to one another but that may be locked in a desired position to fix the spine a desired shape.
[0144] Plication head 202 includes a tapered, atraumatic, distal tip 210 and a proximal portion 212 coupled to one another by one, two or more hinge member 214. In the FIGS. 36A-39 embodiment, three hinge members 214 are shown. Each of the illustrated hinge members includes distal and proximal hinge plates 216a, 216b joined together at central hinge 218. The hinge members 214 are moveable between the generally elongated position shown in FIG. 36A , and to the expanded position of FIG. 36B in which the central hinge 218 extends outwardly and in which the distance separating distal tip 210 and proximal end 212 of the plication head is decreased. As shown as a transparent element in the bottom plan view of FIG. 38A and the end view of FIG. 38B , a membrane or shroud 215 covers the hinge members 214 and is connected to the distal tip 210 and proximal portion 212 of the plication head 202 to form a vacuum chamber 217. An opening 219 in the shroud positionable in contact with stomach wall tissue to allow tissue to be drawn into the chamber during use. Shroud 215 is preferably formed of silicone, elastomeric material, or any other inelastic or elastic flexible or deformable biocompatible material capable of forming a vacuum chamber.
[0145] Referring to FIG. 37A , the proximal portion 212 of the plication head 202 includes a hydraulic chamber 220. The hydraulic chamber 220 is fluidly coupled by a fluid line 222 to a source of fluid 224. An outer piston 226 is disposed within the hydraulic chamber 220. In the illustrated embodiment, piston 226 is a hollow cylinder having a rear wall 228 and a front wall 230. Front wall 230 includes a center cutout 232. An inner piston 234 is disposed within the outer piston 226, and includes a longitudinal plunger 236 extending through the cutout 232.
[0146] Each of the proximal hinge plates 216b includes an inwardly-extending camming surface 238. The hinge plates include proximal pivots 240 such that distally-oriented pressure against camming surfaces 238 causes the hinge plates 216b to pivot about the pivots 240 into the position shown in FIG. 37B .
[0147] Proximal portion 212 of the plication head 202 includes a staple cartridge 242 containing staples arranged in an annular arrangement (not visible in the drawing), and a staple driver 244 positioned to drive staples from the distal end of the cartridge 242 when it is advanced in a distal direction into contact with the staples. Staple driver 244 may include a tissue penetrating element 248 (FIG. 40B ) sufficiently sharp to form a hole in tissue.
[0148] An anvil 246 on the distal tip 210 is positioned to receive the prongs of staples driven by staple driver 242 and to fold the prongs into a closed position. Staple cartridge and anvil arrangements are well known in the surgical and endoscopic stapling art and need not be discussed in further detail. The staples (and sutures) described for use herein may be permanent or bioerodible/biodegradable.
Exemplary Method for Using the Third Preferred Embodiment
[0149] As with the previously discussed methods, a method of using the plication system 200 of the third embodiment is carried out under visualization using an endoscope advanced via the esophagus into the stomach.
[0150] In preparation for use, the plication head is positioned with the hinge members 214 in the streamlined position shown in FIGS. 36A and 37A . The plication head 202 is introduced transorally into the stomach, through an introducer sheath if needed to ensure smooth passage through the esophagus. Pullwires 208 are manipulated to orient the plication head 202 so that the opening 219 in the vacuum chamber 217 (FIGS. 38 and 39 ) is positioned in contact with stomach wall tissue at a location at which a plication is to be formed.
[0151] Next, as shown in FIG. 37B , hydraulic fluid is injected from fluid source 224 into chamber 220. The fluid pressure advances outer piston 226 in a distally direction, causing the front wall 230 of the piston 226 to contact the camming surfaces 238, thus pivoting the pivot plates 216b about proximal pivots 240. In response, hinge members 214 pivot as shown in FIG. 37B until they reach the partially expanded position shown in FIG. 37B . The vacuum source 206 is activated to create a vacuum which draws a pinch of tissue into the vacuum chamber 217, with serosal tissue surfaces generally facing one another as has been described with the other embodiments (see e.g. FIG. 34B ). The flexible nature of the shroud forming the vacuum chamber 217 allows the vacuum chamber 217 to deform outwardly as tissue is drawn into the chamber.
[0152] Once tissue is drawn in to the vacuum chamber 217, additional fluid is directed into the hydraulic chamber 220 to advance the outer piston 226 until the hinge members 214 are in the fully expanded position shown in FIG. 37C . Expansion of the hinge members 214 draws the distal tip 210 towards the proximal portion 212 of the plication head 202. This compresses the tissue within the vacuum chamber 217, bringing the opposed serosal tissue surfaces into contact or close proximity with each other similar to the tissue positions shown in FIG. 34E . Once the tissue is compressed, staples from the cartridge 242 are fired through the tissue by passing the staple pusher 244 through the staple cartridge 242. If the staple pusher 244 is provided with a tissue penetrating element 248 as shown in FIG. 40B , the tissue penetrating element 248 penetrates the opposed layers of stomach wall tissue as the staples are driven through the tissue, forming a hole surrounded by an annular pattern of staples.
[0153] The staples fold against the anvil 246. After stapling, the hinge members are moved to the collapsed position shown in FIG. 36A . The plicator is separated from the tissue and withdrawn from the body. The tapered profile of the proximal portion 212 of the plication head 202 allows the plication head 202 to pass through the gastro-esophageal junction, esophagus, and mouth with minimal trauma.
[0154] In the illustrated embodiment, the staple pusher 244 is driven by the injection of hydraulic fluid into the cylindrical piston 226. The fluid drives plunger 236 distally into contact with the staple pusher 244, which in turns drives through the cartridge 242 to advance the staples. FIG. 40A illustrates one arrangement of the pistons 226, 234 within the hydraulic chamber 220 that will allow this to be achieved. As shown, hydraulic cylinder 220 includes first and second inlets I1 and I2, and the piston 226 includes a third inlet 13. O-ring seals O1, O2 are positioned on the exterior surface of piston 226 and o-ring seals O3 and O4 are positioned on the exterior surface of the inner piston 234. When hydraulic pressure is applied to I1, the piston 226 advances distally (towards the left in the view shown) to expand the hinge members 214 (FIG. 37C ) and compress the tissue as discussed above. After o-ring seal O2 has moved distally of inlet I2, fluid pressure can be directed through I2 and into I3, causing inner piston 234 to be driven distally to advance the staple pusher 244 (FIG. 37A ). Although in the FIG. 40A embodiment the hydraulics for tissue compression and stapling and combined on the proximal side of the plication head, these functions may be separated, with the hydraulics driving one function positioned distally of the vacuum chamber and the hydraulics driving the other function positioned proximally of the vacuum chamber.
[0155] FIGS. 41A and 41B are side elevation views of a modified plication head 202c in which the distal and proximal portions 210c, 212c are coupled by a hinge 214c that is actuated by a lead screw 211. Lead screw is extended as shown in FIG. 41A to elongate the plication head 202c for passage into the body and for expansion of the vacuum chamber which, as with the FIG. 36A embodiment, is defined by a shroud 215 (FIG. 41C ). Once tissue is drawn into the chamber, the lead screw 211 is actuated to bring the distal and proximal portions 210c, 212c into alignment for compression and stapling of the tissue as described above.
Plication Reinforcements
[0156] Reinforcements of various types may be implanted in or on plications formed using the plication system. Such reinforcements may function to reinforce the staple array, help to more evenly distribute the forces applied to the tissue by the staples, and/or facilitate bonding between the opposed serosal layers. Suitable reinforcements include ones positionable on or between the serosal tissue layers (“serosal side reinforcements”), as well as those delivered on the side of the mucosal tissue (“mucosal side reinforcements”).
[0157] Serosal side reinforcements have been discussed in connection with the first and second embodiments. A reinforcement similar to mesh element 24 described in connection with FIGS. 14A , 14B may serve as a permanent or semi-permanent implant that will reinforce the staple array applied to the tissue and/or facilitate serosal tissue bonding between the layers of stomach wall tissue that are to be stapled or sutured together. For this purpose, the material may be a synthetic or non-synthetic mesh (formed of nitinol, polyester, or other natural or synthetic material), porous or non-porous material, slotted material, or any other material through which adhesions will form or onto which tissue will grow. Examples include, but are not limited to, polypropylene, materials sold under the trade names Goretex or Dacron, or tissue graft material such as the Surgisis material sold by Wilson Cook Medical, Inc. The material may be treated with tissue-ingrowth promoting substances such as biologics.
[0158] In an alternative embodiment of a serosal side reinforcement shown in FIGS. 42A and 42B , a reinforcement 270 (which may be formed of a polyester fabric, mesh, or any other material including those listed elsewhere in this application) is carried by a frame 272 having a plurality of outwardly extending arms that spring to an expanded position when released from a hollow tube. The tube might be any of the tubes described above for delivering mesh or sclerosing agents etc. to the serosal tissue, e.g. tube 50g of FIG. 34A . The hollow tube 274 is passed through stomach wall tissue so that its distal end is positioned between serosal layers (e.g., the position of needle 50a in FIG. 26B ). The frame 272 is advanced out the distal end of the needle to allow the arms of the frame to spread to the expanded position shown, thereby expanding the reinforcement between the opposed serosal layers. The reinforcement is fixed between the layers by the staples driven through the opposed regions of stomach wall, and the frame is withdrawn from the needle and out of the body.
[0159] Mucosal side reinforcements may take the form of reinforcements that are positioned on or adjacent to one or both of the mucosal surfaces lining the “pinch” of tissue that will form the plication. These reinforcements may be features of the staples or staple arrays, or they may be separate components engaged by staples as the staples are advanced through the tissue.
[0160] Referring to FIG. 43A , conventional stapling procedures will often include two parallel rows of staples, in which the staples in one row are laterally offset from the staples of the other row. According to the disclosed method, it is useful to employ this technique to the circular staple pattern delivered using the plicators described above, to produce two concentric rings of offset staples 276, as shown in FIG. 43B . It has been found to be additionally beneficial to form mucosal side reinforcements by linking or interlocking the staples to provide greater structural reinforcement to the stapled tissue and/or to more evenly distribute forces applied to the tissue by the staples. Linked staple arrays may be formed by arranging the staples 276 in the cartridge of the plicator in a single circular pattern to interlock as shown in FIG. 43C , or in a double circular pattern with two concentric rings of interlocked staples. The staples 276a may be curvilinear so as to form a locking pattern shown in perspective view of FIG. 43D . A linear arrangement of staples 276 may also be linked as shown in FIG. 43E .
[0161] In alternative embodiments, staples are linked together by reinforcing members formed of metallic or polymeric materials, such as nitinol, titanium, stainless steel PEEK, or other biocompatible materials including those that are bioerodible/biodegradable. According to these embodiments, the reinforcing members are positioned on one or both of the mucosal sides of the “pinch” of tissue engaged by the plication system such that they are captured by staples being driven through the tissue. In a preferred embodiment, the staples capture a cartridge side reinforcing ring 278 (FIG. 13A ) as they leave the cartridge and capture an anvil side reinforcing ring 280 (FIG. 44B ) as the anvil shapes and bends them. Upon completion of the plication, the staples are linked to one another so that they cannot separate or expand radially. The rings promote even distribution of forces around the ring of staples.
[0162] The reinforcing rings are preferably provided separate from the staples although they instead may be integral with the staples. In the illustrated embodiment, ring 280 is positioned against the staple anvil 246 as shown in FIG. 45A . Ring 278 is seated within the cartridge 242 (FIG. 45B ), with the staples 276 aligned with their prongs 282 extending through a plurality of the loops 284 in the ring 278. When staples 276 are driven from the cartridge, they capture ring 278 against the adjacent mucosal tissue as shown in FIG. 46A . The staple legs/prongs 282 pass through the stomach wall tissue into contact with the indentations 286 of the anvil 246. When they contact the anvil 246, the prongs 282 fold around the staple ring 280 to capture the ring 280 and interlock the staples on the anvil side of the plication as shown in FIG. 46B . Rings or other interlocking elements of this type may be used with single- or double-staple row configurations.
[0163] Rings 278, 280 are shown as generally circular, although alternative reinforcements of different shapes and patterns may also be used, including those shaped to accommodate linear, oval and other staple patterns.
Applications for Cutout Plications
[0164] FIGS. 47A through 49 illustrate examples of applications for cutout plications formed within the stomach using any methods or system, including those described above. As shown, the cutout plications can eliminate the need for anchor loops of the type described in connection with the first embodiment. Each of these applications is preferably (but optionally) performed in a separate procedure from that in which the plications are formed, so as to allow serosal bonding to occur before the plicated tissue is subjected to stresses imparted by implants and/or further manipulation.
[0165] A first application shown in FIGS. 47A through 47C uses two or more cutout plications CP, preferably formed at the gastro-esophageal junction region of the stomach. According to this application, the cutouts C of the plications are brought into partial or full alignment with one another (FIGS. 47A and 47B ) using an endoscope or another endoscopic instrument. A restrictive implant such as the implant 4 shown in FIG. 4 is threaded through the aligned cutouts while in a radially-collapsed position, and is then allowed to expand to the position shown in FIG. 47C . Instruments and methods for orienting and expanding an implant of this type are shown and described in U.S. application Ser. No. 11/439,461, filed May 23, 2006. Once in place, the implant greatly reduces the amount of food a patient can consume, by slowing the rate at which food can descend from the esophagus into the stomach.
[0166] In the method shown in FIG. 48A , multiple cutout plications CP are formed in select positions allowing the plications to be drawn together so as to significantly narrow the channel through which food can pass through the stomach. For example, the plications CP of FIG. 48A are arranged such that manipulating the plications to place their cutouts C in alignment causes the plications themselves to form a barrier against passage of food. This arrangement limits most food flow to a narrow food passage FP and creates a gastric pouch GP adjacent to the food passage. An implant 4a is positioned within the cutouts C as described above to retain the plications CP in their gathered arrangement. The implant 4a may have a similar configuration to the implant 4 of FIG. 4 , including a through-hole allowing some passage of food through the implant, or it may be impenetrable by food thus forming a plug largely preventing passage of food and gastric juices through the cutouts C. The implant may include a valve oriented to minimize restriction of food flow out of the stomach during vomiting. Other implants that will retain the gathered configuration of the plications CP may alternatively be used, including lengths of biocompatible material passed through the cutouts and knotted or otherwise fastened into loops. In other embodiments, the collective sizes and numbers of the plications may themselves be sufficient to restrict flow of food into the stomach, without the need for any implants to connect them to one another.
[0167] In either embodiment, if the implant 4, 4a is to be removed or replaced with an implant of different dimensions (e.g. so as to slow the rate of weight loss following a period of significant weight loss, or to increase the rate of weight loss), endoscopic instruments may be used to withdraw the implant from the cutouts C and to remove the implant from the stomach.
[0168] In another embodiment shown in FIG. 49 , a restrictive pouch 4b may include anchors 5 that are inserted into cutout plications CP. Anchors 5 are shown as having a button shape, but they may alternatively be other structures including loops that close on themselves to prevent detachment from the cutout, or they might be legs of the type disclosed in WO 2005/037152.
[0169] As is evident from above, the disclosed endoscopic systems function to draw a tissue into the stomach to form a depression on the exterior surface of the stomach, and staple (or suture, or fasten or adhere etc) the opposed stomach wall sections lining the depression together another to form a plication. The system may additionally place material of a type that will promote strong tissue adhesion within the depression (on the exterior of the stomach) and retain the material between the serosal surfaces to enhance. Additionally or alternatively, mucosal reinforcements such as structures that interconnect the staples may be implanted. While these systems provide convenient embodiments for carrying out this function, there are many other widely varying instruments or systems may alternatively be used within the scope of the present invention. Moreover, the disclosed embodiments may be combined with one another in varying ways to produce additional embodiments. Thus, the embodiments described herein should be treated as representative examples of systems useful for forming endoscopic tissue plications, and should not be used to limit the scope of the claimed invention.
[0170] Any and all patents, patent applications and printed publications referred to above, including those relied upon for purposes of priority, are incorporated herein by reference.
Claims
What is claimed is:
1. An apparatus for forming a stapled tissue fold composed of opposed sections of tissue, comprising:
(i) a first member having a tissue-contact surface wherein the first member includes a staple housing having a staple cartridge including at least one staple;
(ii) a second member having a tissue-contact surface that confronts the tissue-contact surface of the first member;
(iii) one or more hinge members coupling the first member and the second member for movement along an axis toward and away from one another, each of said hinge members having proximal and distal sections that are pivotally mounted on said first and second members, respectively, and pivotally joined together at a central hinge, such that movement of the two members toward one another causes the proximal and distal sections of each hinge member to pivot outwardly away from said axis, and
(iv) a vacuum chamber defined by said hinge members and the confronting tissue-contact surfaces of the first and second members, and including a flexible membrane extending between the two members, covering said hinge member(s), and providing an opening through which tissue can be drawn into the chamber;
such that application of the vacuum to said chamber is effective to draw a tissue fold into said chamber, through said membrane opening, and movement of the two members toward one another is effective (i) to enlarge the size of the chamber in the region between the two members, increasing the size of the tissue fold that can be drawn into the chamber upon application of a vacuum, and (ii) ultimately to capture the tissue fold between the confronting tissue-contact surfaces of said two members.
2. The apparatus of claim 1, wherein said membrane is formed of silicone.
3. The apparatus of claim 1, wherein the tissue-contact surface of the second member provides an anvil surface.
4. The apparatus of claim 1, furthering comprising a cutter carried on the first member and extendable through tissue in the vacuum chamber to form a hole in the tissue fold.
5. A method of forming a stapled tissue fold composed of opposed sections of tissue with the apparatus of claim 1, comprising
(i) drawing a tissue fold into the vacuum chamber defined by the confronting tissue-contact surfaces of the first and second members and the hinge member(s) pivotally coupling the two members in the apparatus, and including the flexible membrane extending between the two members, conveying said hinge members and providing an opening through which tissue can be drawn in to the chamber, by applying a vacuum to said chamber;
(ii) moving the first member and the second member toward one another;
(iii) by said moving, enlarging the size of the chamber in the region between the two members, thereby increasing the size of the tissue fold that can be drawn into the chamber upon application of a vacuum,
(iv) with continued moving the first member and the second member toward one another ultimately capturing the tissue fold between the confronting tissue-contact surfaces of said two members and
(v) stapling the tissue fold.
7. The method of claim 6, further comprising:
coupling an anchor to the tissue fold by passing one end of the anchor through the hole in the tissue fold.
8. The method of claim 5, for use in forming a stapled tissue plication within a patient's stomach, further comprising:
positioning a reinforcing element against the tissue-fold surface in contact with the tissue-contact surface of the first member before said stapling.
9. The method of claim 5, wherein stapling the tissue fold comprises stapling a circular array of staples in the tissue fold.
Patent Citations (433)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US1408865(A) | 1922-03-01 | Cowell | Applicant |
| US3663965(A) | 1972-05-01 | Lee et al. | Applicant |
| US4134405(A) | 1979-01-01 | Smit | Applicant |
| US4207890(A) | 1980-06-01 | Mamajek et al. | Applicant |
| US4246893(A) | 1981-01-01 | Berson | Applicant |
| US4315509(A) | 1982-02-01 | Smit | Applicant |
| US4331277(A) | 1982-05-01 | Green | Applicant |
| US4403604(A) | 1983-09-01 | Wilkinson et al. | Applicant |
| US4416267(A) | 1983-11-01 | Garren et al. | Applicant |
| US4417360(A) | 1983-11-01 | Moasser | Applicant |
| US4441215(A) | 1984-04-01 | Kaster | Applicant |
| US4467804(A) | 1984-08-01 | Hardy et al. | Applicant |
| US4485805(A) | 1984-12-01 | Foster, Jr. | Applicant |
| US4488523(A) | 1984-12-01 | Shichman | Applicant |
| US4501264(A) | 1985-02-01 | Rockey | Applicant |
| US4607618(A) | 1986-08-01 | Angelchik | Applicant |
| US4641653(A) | 1987-02-01 | Rockey | Applicant |
| US4648383(A) | 1987-03-01 | Angelchik | Applicant |
| US4694827(A) | 1987-09-01 | Weiner et al. | Applicant |
| US4723547(A) | 1988-02-01 | Kullas et al. | Applicant |
| US4747849(A) | 1988-05-01 | Galtier | Applicant |
| US4846836(A) | 1989-07-01 | Reich | Applicant |
| US4848367(A) | 1989-07-01 | Avant et al. | Applicant |
| US4899747(A) | 1990-02-01 | Garren et al. | Applicant |
| US4925446(A) | 1990-05-01 | Garay et al. | Applicant |
| US4946440(A) | 1990-08-01 | Hall | Applicant |
| US4969896(A) | 1990-11-01 | Shors | Applicant |
| US4997084(A) | 1991-03-01 | Opie et al. | Applicant |
| US5006106(A) | 1991-04-01 | Angelchik | Applicant |
| US5037021(A) | 1991-08-01 | Mills et al. | Applicant |
| US5061275(A) | 1991-10-01 | Wallsten et al. | Applicant |
| US5084061(A) | 1992-01-01 | Gau et al. | Applicant |
| US5088979(A) | 1992-02-01 | Filipi et al. | Applicant |
| US5163952(A) | 1992-11-01 | Froix | Applicant |
| US5211658(A) | 1993-05-01 | Clouse | Applicant |
| US5234454(A) | 1993-08-01 | Bangs | Applicant |
| US5246456(A) | 1993-09-01 | Wilkinson | Applicant |
| US5259399(A) | 1993-11-01 | Brown | Applicant |
| US5263629(A) | 1993-11-01 | Trumbull et al. | Applicant |
| US5290217(A) | 1994-03-01 | Campos | Applicant |
| US5306300(A) | 1994-04-01 | Berry | Applicant |
| US5314473(A) | 1994-05-01 | Godin | Applicant |
| US5327914(A) | 1994-07-01 | Shlain | Applicant |
| US5345949(A) | 1994-09-01 | Shlain | Applicant |
| US5355897(A) | 1994-10-01 | Pietrafitta et al. | Applicant |
| US5401241(A) | 1995-03-01 | Delany | Applicant |
| US5403326(A) | 1995-04-01 | Harrison et al. | Applicant |
| US5405377(A) | 1995-04-01 | Cragg | Applicant |
| US5431673(A) | 1995-07-01 | Summers et al. | Applicant |
| US5486187(A) | 1996-01-01 | Schenck | Applicant |
| US5514176(A) | 1996-05-01 | Bosley, Jr. | Applicant |
| US5535935(A) | 1996-07-01 | Vidal et al. | Applicant |
| US5542949(A) | 1996-08-01 | Yoon | Applicant |
| US5562239(A) | 1996-10-01 | Boiarski et al. | Applicant |
| US5571116(A) | 1996-11-01 | Bolanos et al. | Applicant |
| US5577654(A) | 1996-11-01 | Bishop | Applicant |
| US5593434(A) | 1997-01-01 | Williams | Applicant |
| US5597107(A) | 1997-01-01 | Knodel et al. | Applicant |
| US5609624(A) | 1997-03-01 | Kalis | Applicant |
| US5628786(A) | 1997-05-01 | Banas et al. | Applicant |
| US5630539(A) | 1997-05-01 | Plyley et al. | Applicant |
| US5647526(A) | 1997-07-01 | Green et al. | Applicant |
| US5653743(A) | 1997-08-01 | Martin | Applicant |
| US5662713(A) | 1997-09-01 | Andersen et al. | Applicant |
| US5673841(A) | 1997-10-01 | Schulze et al. | Applicant |
| US5674241(A) | 1997-10-01 | Bley et al. | Applicant |
| US5706998(A) | 1998-01-01 | Plyley et al. | Applicant |
| US5709657(A) | 1998-01-01 | Zimmon | Applicant |
| US5720776(A) | 1998-02-01 | Chuter et al. | Applicant |
| US5749918(A) | 1998-05-01 | Hogendijk et al. | Applicant |
| US5762255(A) | 1998-06-01 | Chrisman et al. | Applicant |
| US5771903(A) | 1998-06-01 | Jakobsson | Applicant |
| US5785684(A) | 1998-07-01 | Zimmon | Applicant |
| US5820584(A) | 1998-10-01 | Crabb | Applicant |
| US5839639(A) | 1998-11-01 | Sauer et al. | Applicant |
| US5848964(A) | 1998-12-01 | Samuels | Applicant |
| US5855311(A) | 1999-01-01 | Hamblin et al. | Applicant |
| US5855601(A) | 1999-01-01 | Bessler et al. | Applicant |
| US5856445(A) | 1999-01-01 | Korsmeyer | Applicant |
| US5861036(A) | 1999-01-01 | Godin | Applicant |
| US5868141(A) | 1999-02-01 | Ellias | Applicant |
| US5887594(A) | 1999-03-01 | LoCicero et al. | Applicant |
| US5897562(A) | 1999-04-01 | Bolanos et al. | Applicant |
| US5910144(A) | 1999-06-01 | Hayashi et al. | Applicant |
| US5922019(A) | 1999-07-01 | Hankh et al. | Applicant |
| US5947983(A) | 1999-09-01 | Solar et al. | Applicant |
| US5993473(A) | 1999-11-01 | Chan et al. | Applicant |
| US5993483(A) | 1999-11-01 | Gianotti | Applicant |
| US6016848(A) | 2000-01-01 | Egres, Jr. | Applicant |
| US6051015(A) | 2000-04-01 | Maahs | Applicant |
| US6086600(A) | 2000-07-01 | Kortenbach | Applicant |
| US6098629(A) | 2000-08-01 | Johnson et al. | Applicant |
| US6102922(A) | 2000-08-01 | Jakobsson et al. | Applicant |
| US6113609(A) | 2000-09-01 | Adams | Applicant |
| US6120534(A) | 2000-09-01 | Ruiz | Applicant |
| US6126058(A) | 2000-10-01 | Adams et al. | Applicant |
| US6146416(A) | 2000-11-01 | Andersen et al. | Applicant |
| US6159146(A) | 2000-12-01 | El Gazayerli | Applicant |
| US6159238(A) | 2000-12-01 | Killion et al. | Applicant |
| US6197022(B1) | 2001-03-01 | Baker | Applicant |
| US6206930(B1) | 2001-03-01 | Burg et al. | Applicant |
| US6238414(B1) | 2001-05-01 | Griffiths | Examiner |
| US6245088(B1) | 2001-06-01 | Lowery | Applicant |
| US6251132(B1) | 2001-06-01 | Ravenscroft et al. | Applicant |
| US6254642(B1) | 2001-07-01 | Taylor | Applicant |
| US6258120(B1) | 2001-07-01 | McKenzie et al. | Applicant |
| US6264700(B1) | 2001-07-01 | Kilcoyne et al. | Applicant |
| US6287334(B1) | 2001-09-01 | Moll et al. | Applicant |
| US6302917(B1) | 2001-10-01 | Dua et al. | Applicant |
| US6358197(B1) | 2002-03-01 | Silverman | Applicant |
| US6416522(B1) | 2002-07-01 | Strecker | Applicant |
| US6425916(B1) | 2002-07-01 | Garrison et al. | Applicant |
| US6454785(B2) | 2002-09-01 | De Hoyos Garza | Applicant |
| US6460543(B1) | 2002-10-01 | Forsell | Applicant |
| US6461366(B1) | 2002-10-01 | Seguin | Applicant |
| US6494888(B1) | 2002-12-01 | Laufer et al. | Applicant |
| US6494895(B2) | 2002-12-01 | Addis | Applicant |
| US6503264(B1) | 2003-01-01 | Birk | Applicant |
| US6506196(B1) | 2003-01-01 | Laufer et al. | Applicant |
| US6527784(B2) | 2003-03-01 | Adams et al. | Applicant |
| US6540789(B1) | 2003-04-01 | Silverman et al. | Applicant |
| US6544291(B2) | 2003-04-01 | Taylor | Applicant |
| US6547801(B1) | 2003-04-01 | Dargent et al. | Applicant |
| US6558400(B2) | 2003-05-01 | Deem et al. | Applicant |
| US6558429(B2) | 2003-05-01 | Taylor et al. | Applicant |
| US6572627(B2) | 2003-06-01 | Gabbay | Applicant |
| US6572629(B2) | 2003-06-01 | Kalloo | Applicant |
| US6575896(B2) | 2003-06-01 | Silverman | Applicant |
| US6592596(B1) | 2003-07-01 | Geitz | Applicant |
| US6596023(B1) | 2003-07-01 | Nunez et al. | Applicant |
| US6607555(B2) | 2003-08-01 | Patterson et al. | Applicant |
| US6627206(B2) | 2003-09-01 | Lloyd | Applicant |
| US6632227(B2) | 2003-10-01 | Adams | Examiner |
| US6648897(B2) | 2003-11-01 | Hamilton | Examiner |
| US6663639(B1) | 2003-12-01 | Laufer | Applicant |
| US6675809(B2) | 2004-01-01 | Stack et al. | Applicant |
| US6740098(B2) | 2004-05-01 | Abrams et al. | Applicant |
| US6740121(B2) | 2004-05-01 | Geitz | Applicant |
| US6746460(B2) | 2004-06-01 | Gannoe et al. | Applicant |
| US6755869(B2) | 2004-06-01 | Geitz | Applicant |
| US6764518(B2) | 2004-07-01 | Godin | Applicant |
| US6773440(B2) | 2004-08-01 | Gannoe et al. | Applicant |
| US6773441(B1) | 2004-08-01 | Laufer et al. | Applicant |
| US6790214(B2) | 2004-09-01 | Kraemer et al. | Applicant |
| US6790237(B2) | 2004-09-01 | Stinson | Applicant |
| US6821285(B2) | 2004-11-01 | Laufer et al. | Applicant |
| US6835200(B2) | 2004-12-01 | Laufer et al. | Applicant |
| US6845776(B2) | 2005-01-01 | Stack et al. | Applicant |
| US6916332(B2) | 2005-07-01 | Adams | Applicant |
| US6932838(B2) | 2005-08-01 | Schwartz et al. | Applicant |
| US6960233(B1) | 2005-11-01 | Berg et al. | Applicant |
| US6966875(B1) | 2005-11-01 | Longobardi | Applicant |
| US6981978(B2) | 2006-01-01 | Gannoe | Applicant |
| US6981980(B2) | 2006-01-01 | Sampson et al. | Applicant |
| US6994715(B2) | 2006-02-01 | Gannoe et al. | Applicant |
| US7011094(B2) | 2006-03-01 | Rapackie et al. | Applicant |
| US7020531(B1) | 2006-03-01 | Colliou et al. | Applicant |
| US7025791(B2) | 2006-04-01 | Levine et al. | Applicant |
| US7033373(B2) | 2006-04-01 | de la Torre et al. | Applicant |
| US7033384(B2) | 2006-04-01 | Gannoe et al. | Applicant |
| US7037344(B2) | 2006-05-01 | Kagan et al. | Applicant |
| US7056305(B2) | 2006-06-01 | Garza | Applicant |
| US7066945(B2) | 2006-06-01 | Hashiba et al. | Applicant |
| US7083629(B2) | 2006-08-01 | Weller et al. | Applicant |
| US7090699(B2) | 2006-08-01 | Geitz | Applicant |
| US7097650(B2) | 2006-08-01 | Weller et al. | Applicant |
| US7097665(B2) | 2006-08-01 | Stack et al. | Applicant |
| US7111627(B2) | 2006-09-01 | Stack et al. | Applicant |
| US7112186(B2) | 2006-09-01 | Shah | Applicant |
| US7118528(B1) | 2006-10-01 | Piskun | Examiner |
| US7120498(B2) | 2006-10-01 | Imran et al. | Applicant |
| US7121283(B2) | 2006-10-01 | Stack et al. | Applicant |
| US7141055(B2) | 2006-11-01 | Abrams et al. | Applicant |
| US7146984(B2) | 2006-12-01 | Stack et al. | Applicant |
| US7147140(B2) | 2006-12-01 | Wukusick et al. | Applicant |
| US7152607(B2) | 2006-12-01 | Stack et al. | Applicant |
| US7160312(B2) | 2007-01-01 | Saadat et al. | Applicant |
| US7172613(B2) | 2007-02-01 | Wazne | Applicant |
| US7175638(B2) | 2007-02-01 | Gannoe et al. | Applicant |
| US7175660(B2) | 2007-02-01 | Cartledge et al. | Applicant |
| US7211114(B2) | 2007-05-01 | Bessler et al. | Applicant |
| US7214233(B2) | 2007-05-01 | Gannoe et al. | Applicant |
| US7220237(B2) | 2007-05-01 | Gannoe et al. | Applicant |
| US7220284(B2) | 2007-05-01 | Kagan et al. | Applicant |
| US7223277(B2) | 2007-05-01 | DeLegge | Applicant |
| US7229428(B2) | 2007-06-01 | Gannoe et al. | Applicant |
| US7229453(B2) | 2007-06-01 | Anderson et al. | Applicant |
| US7255675(B2) | 2007-08-01 | Gertner et al. | Applicant |
| US7261722(B2) | 2007-08-01 | McGuckin, Jr. et al. | Applicant |
| US7288101(B2) | 2007-10-01 | Deem et al. | Applicant |
| US7306614(B2) | 2007-12-01 | Weller et al. | Applicant |
| US7315509(B2) | 2008-01-01 | Jeong et al. | Applicant |
| US7316716(B2) | 2008-01-01 | Egan | Applicant |
| US7320696(B2) | 2008-01-01 | Gazi et al. | Applicant |
| US7326207(B2) | 2008-02-01 | Edwards | Applicant |
| US7335210(B2) | 2008-02-01 | Smit | Applicant |
| US7347863(B2) | 2008-03-01 | Rothe et al. | Applicant |
| US7347875(B2) | 2008-03-01 | Levine et al. | Applicant |
| US7354454(B2) | 2008-04-01 | Stack et al. | Applicant |
| US7399304(B2) | 2008-07-01 | Gambale et al. | Applicant |
| US7431725(B2) | 2008-10-01 | Stack et al. | Applicant |
| US7461767(B2) | 2008-12-01 | Viola et al. | Applicant |
| US7470251(B2) | 2008-12-01 | Shah | Applicant |
| US7485142(B2) | 2009-02-01 | Milo | Applicant |
| US7503922(B2) | 2009-03-01 | Deem et al. | Applicant |
| US7520884(B2) | 2009-04-01 | Swanstrom et al. | Applicant |
| US7575586(B2) | 2009-08-01 | Berg et al. | Applicant |
| US7628821(B2) | 2009-12-01 | Stack et al. | Applicant |
| US7662161(B2) | 2010-02-01 | Briganti et al. | Applicant |
| US7670279(B2) | 2010-03-01 | Gertner | Applicant |
| US7674271(B2) | 2010-03-01 | Bjerken | Applicant |
| US7708181(B2) | 2010-05-01 | Cole et al. | Applicant |
| US7717843(B2) | 2010-05-01 | Balbierz et al. | Applicant |
| US2001/0011543(A1) | 2001-08-01 | Forsell | Applicant |
| US2001/0020189(A1) | 2001-09-01 | Taylor | Applicant |
| US2001/0020190(A1) | 2001-09-01 | Taylor | Applicant |
| US2001/0021796(A1) | 2001-09-01 | Silverman et al. | Applicant |
| US2001/0044595(A1) | 2001-11-01 | Reydel et al. | Applicant |
| US2002/0022851(A1) | 2002-02-01 | Kalloo et al. | Applicant |
| US2002/0055757(A1) | 2002-05-01 | Torre et al. | Applicant |
| US2002/0072761(A1) | 2002-06-01 | Abrams et al. | Applicant |
| US2002/0082621(A1) | 2002-06-01 | Schurr et al. | Applicant |
| US2002/0099439(A1) | 2002-07-01 | Schwartz et al. | Applicant |
| US2002/0183767(A1) | 2002-12-01 | Adams et al. | Applicant |
| US2002/0183768(A1) | 2002-12-01 | Deem et al. | Applicant |
| US2003/0009236(A1) | 2003-01-01 | Godin | Applicant |
| US2003/0040804(A1) | 2003-02-01 | Stack et al. | Applicant |
| US2003/0040808(A1) | 2003-02-01 | Stack et al. | Applicant |
| US2003/0065359(A1) | 2003-04-01 | Weller et al. | Applicant |
| US2003/0093117(A1) | 2003-05-01 | Saadat | Applicant |
| US2003/0109892(A1) | 2003-06-01 | Deem et al. | Applicant |
| US2003/0120289(A1) | 2003-06-01 | McGuckin et al. | Examiner |
| US2003/0132267(A1) | 2003-07-01 | Adams et al. | Examiner |
| US2003/0139752(A1) | 2003-07-01 | Pasricha et al. | Examiner |
| US2003/0158569(A1) | 2003-08-01 | Wazne | Applicant |
| US2003/0183671(A1) | 2003-10-01 | Mooradian et al. | Applicant |
| US2003/0191476(A1) | 2003-10-01 | Smit | Applicant |
| US2003/0199989(A1) | 2003-10-01 | Stack et al. | Applicant |
| US2003/0199990(A1) | 2003-10-01 | Stack et al. | Applicant |
| US2003/0199991(A1) | 2003-10-01 | Stack et al. | Applicant |
| US2003/0208209(A1) | 2003-11-01 | Gambale et al. | Examiner |
| US2003/0220660(A1) | 2003-11-01 | Kortenbach et al. | Applicant |
| US2004/0006351(A1) | 2004-01-01 | Gannoe et al. | Examiner |
| US2004/0024386(A1) | 2004-02-01 | Deem et al. | Applicant |
| US2004/0030347(A1) | 2004-02-01 | Gannoe et al. | Applicant |
| US2004/0044353(A1) | 2004-03-01 | Gannoe | Applicant |
| US2004/0044354(A1) | 2004-03-01 | Gannoe et al. | Applicant |
| US2004/0044357(A1) | 2004-03-01 | Gannoe et al. | Applicant |
| US2004/0044364(A1) | 2004-03-01 | DeVries et al. | Applicant |
| US2004/0082963(A1) | 2004-04-01 | Gannoe et al. | Applicant |
| US2004/0088023(A1) | 2004-05-01 | Imran et al. | Applicant |
| US2004/0092892(A1) | 2004-05-01 | Kagan et al. | Applicant |
| US2004/0092960(A1) | 2004-05-01 | Abrams et al. | Examiner |
| US2004/0092974(A1) | 2004-05-01 | Gannoe et al. | Applicant |
| US2004/0093091(A1) | 2004-05-01 | Gannoe et al. | Applicant |
| US2004/0098043(A1) | 2004-05-01 | Trout | Applicant |
| US2004/0107004(A1) | 2004-06-01 | Levine et al. | Applicant |
| US2004/0117031(A1) | 2004-06-01 | Stack et al. | Applicant |
| US2004/0138682(A1) | 2004-07-01 | Onuki et al. | Examiner |
| US2004/0138761(A1) | 2004-07-01 | Stack et al. | Applicant |
| US2004/0143342(A1) | 2004-07-01 | Stack et al. | Applicant |
| US2004/0148034(A1) | 2004-07-01 | Kagan et al. | Applicant |
| US2004/0153167(A1) | 2004-08-01 | Stack et al. | Applicant |
| US2004/0158331(A1) | 2004-08-01 | Stack et al. | Applicant |
| US2004/0162568(A1) | 2004-08-01 | Saadat et al. | Applicant |
| US2004/0172141(A1) | 2004-09-01 | Stack et al. | Applicant |
| US2004/0172142(A1) | 2004-09-01 | Stack et al. | Applicant |
| US2004/0186502(A1) | 2004-09-01 | Sampson et al. | Applicant |
| US2004/0210243(A1) | 2004-10-01 | Gannoe et al. | Applicant |
| US2004/0215216(A1) | 2004-10-01 | Gannoe et al. | Applicant |
| US2004/0220682(A1) | 2004-11-01 | Levine et al. | Applicant |
| US2004/0225183(A1) | 2004-11-01 | Michlitsch et al. | Applicant |
| US2004/0225305(A1) | 2004-11-01 | Ewers et al. | Applicant |
| US2004/0236419(A1) | 2004-11-01 | Milo | Applicant |
| US2004/0243152(A1) | 2004-12-01 | Taylor et al. | Applicant |
| US2004/0243223(A1) | 2004-12-01 | Kraemer et al. | Applicant |
| US2004/0267378(A1) | 2004-12-01 | Gazi et al. | Applicant |
| US2005/0004430(A1) | 2005-01-01 | Lee et al. | Applicant |
| US2005/0004681(A1) | 2005-01-01 | Stack et al. | Applicant |
| US2005/0033326(A1) | 2005-02-01 | Briganti et al. | Applicant |
| US2005/0033345(A1) | 2005-02-01 | DeLegge | Applicant |
| US2005/0049718(A1) | 2005-03-01 | Dann et al. | Applicant |
| US2005/0059996(A1) | 2005-03-01 | Bauman et al. | Examiner |
| US2005/0075654(A1) | 2005-04-01 | Kelleher | Applicant |
| US2005/0080444(A1) | 2005-04-01 | Kraemer et al. | Applicant |
| US2005/0085787(A1) | 2005-04-01 | Laufer et al. | Applicant |
| US2005/0096673(A1) | 2005-05-01 | Stack et al. | Applicant |
| US2005/0096750(A1) | 2005-05-01 | Kagan et al. | Applicant |
| US2005/0149114(A1) | 2005-07-01 | Cartledge et al. | Applicant |
| US2005/0159769(A1) | 2005-07-01 | Alverdy | Applicant |
| US2005/0177176(A1) | 2005-08-01 | Gerbi et al. | Examiner |
| US2005/0177181(A1) | 2005-08-01 | Kagan et al. | Applicant |
| US2005/0183732(A1) | 2005-08-01 | Edwards | Applicant |
| US2005/0192599(A1) | 2005-09-01 | Demarais | Applicant |
| US2005/0192615(A1) | 2005-09-01 | Torre et al. | Applicant |
| US2005/0203547(A1) | 2005-09-01 | Weller et al. | Applicant |
| US2005/0203548(A1) | 2005-09-01 | Weller et al. | Applicant |
| US2005/0216040(A1) | 2005-09-01 | Gertner et al. | Applicant |
| US2005/0216042(A1) | 2005-09-01 | Gertner | Applicant |
| US2005/0240279(A1) | 2005-10-01 | Kagan et al. | Applicant |
| US2005/0247320(A1) | 2005-11-01 | Stack et al. | Applicant |
| US2005/0250980(A1) | 2005-11-01 | Swanstrom et al. | Applicant |
| US2005/0251158(A1) | 2005-11-01 | Saadat et al. | Applicant |
| US2005/0251162(A1) | 2005-11-01 | Rothe et al. | Applicant |
| US2005/0256533(A1) | 2005-11-01 | Roth et al. | Applicant |
| US2005/0256587(A1) | 2005-11-01 | Egan | Applicant |
| US2005/0261712(A1) | 2005-11-01 | Balbierz et al. | Applicant |
| US2005/0267405(A1) | 2005-12-01 | Shah | Applicant |
| US2005/0267499(A1) | 2005-12-01 | Stack et al. | Applicant |
| US2005/0267595(A1) | 2005-12-01 | Chen et al. | Applicant |
| US2005/0267596(A1) | 2005-12-01 | Chen et al. | Applicant |
| US2005/0273060(A1) | 2005-12-01 | Levy et al. | Applicant |
| US2006/0015006(A1) | 2006-01-01 | Laurence et al. | Applicant |
| US2006/0020278(A1) | 2006-01-01 | Burnett et al. | Applicant |
| US2006/0058829(A1) | 2006-03-01 | Sampson et al. | Applicant |
| US2006/0129094(A1) | 2006-06-01 | Shah | Applicant |
| US2006/0151568(A1) | 2006-07-01 | Weller et al. | Applicant |
| US2006/0155259(A1) | 2006-07-01 | MacLay | Applicant |
| US2006/0155311(A1) | 2006-07-01 | Hashiba et al. | Applicant |
| US2006/0178560(A1) | 2006-08-01 | Saadat et al. | Applicant |
| US2006/0178691(A1) | 2006-08-01 | Binmoeller | Applicant |
| US2006/0195139(A1) | 2006-08-01 | Gertner | Applicant |
| US2006/0253142(A1) | 2006-11-01 | Bjerken | Applicant |
| US2006/0271076(A1) | 2006-11-01 | Weller et al. | Applicant |
| US2006/0282095(A1) | 2006-12-01 | Stokes et al. | Applicant |
| US2006/0287734(A1) | 2006-12-01 | Stack et al. | Applicant |
| US2007/0010864(A1) | 2007-01-01 | Dann et al. | Applicant |
| US2007/0032800(A1) | 2007-02-01 | Ortiz et al. | Applicant |
| US2007/0043384(A1) | 2007-02-01 | Ortiz et al. | Applicant |
| US2007/0055292(A1) | 2007-03-01 | Ortiz et al. | Applicant |
| US2007/0060932(A1) | 2007-03-01 | Stack et al. | Applicant |
| US2007/0149994(A1) | 2007-06-01 | Sosnowski et al. | Applicant |
| US2007/0175488(A1) | 2007-08-01 | Cox et al. | Applicant |
| US2007/0191870(A1) | 2007-08-01 | Baker et al. | Applicant |
| US2007/0191871(A1) | 2007-08-01 | Baker et al. | Applicant |
| US2007/0198074(A1) | 2007-08-01 | Dann et al. | Applicant |
| US2007/0219571(A1) | 2007-09-01 | Balbierz et al. | Applicant |
| US2007/0239284(A1) | 2007-10-01 | Skerven et al. | Applicant |
| US2007/0260327(A1) | 2007-11-01 | Case et al. | Applicant |
| US2007/0276432(A1) | 2007-11-01 | Stack et al. | Applicant |
| US2008/0033574(A1) | 2008-02-01 | Bessler et al. | Applicant |
| US2008/0065122(A1) | 2008-03-01 | Stack et al. | Applicant |
| US2008/0116244(A1) | 2008-05-01 | Rethy et al. | Applicant |
| US2008/0190989(A1) | 2008-08-01 | Crews et al. | Applicant |
| US2008/0195226(A1) | 2008-08-01 | Williams et al. | Applicant |
| US2008/0208355(A1) | 2008-08-01 | Stack et al. | Applicant |
| US2008/0208356(A1) | 2008-08-01 | Stack et al. | Applicant |
| US2008/0269797(A1) | 2008-10-01 | Stack et al. | Applicant |
| US2008/0294179(A1) | 2008-11-01 | Balbierz et al. | Applicant |
| US2009/0018558(A1) | 2009-01-01 | Laufer et al. | Applicant |
| US2009/0024143(A1) | 2009-01-01 | Crews et al. | Applicant |
| US2009/0030284(A1) | 2009-01-01 | Cole et al. | Applicant |
| US2009/0125040(A1) | 2009-05-01 | Hambley et al. | Applicant |
| US2009/0171383(A1) | 2009-07-01 | Cole et al. | Applicant |
| US2009/0177215(A1) | 2009-07-01 | Stack et al. | Applicant |
| US2009/0236388(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236389(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236390(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236391(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236392(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236394(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236396(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236397(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236398(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236400(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0236401(A1) | 2009-09-01 | Cole et al. | Applicant |
| US2009/0299487(A1) | 2009-12-01 | Stack et al. | Applicant |
| US2010/0016988(A1) | 2010-01-01 | Stack et al. | Applicant |
| US2010/0100109(A1) | 2010-04-01 | Stack et al. | Applicant |
| US2010/0116867(A1) | 2010-05-01 | Balbierz et al. | Applicant |
| CH680263(A5) | 1992-07-01 | Applicant | |
| EP775471 | 1997-05-01 | Applicant | |
| EP1256318(A1) | 2002-11-01 | Applicant | |
| EP1492478 | 2005-01-01 | Applicant | |
| EP1602336(A2) | 2005-12-01 | Applicant | |
| FR2768324(A1) | 1999-03-01 | Applicant | |
| JP9-168597 | 1997-06-01 | Applicant | |
| WO91/01117 | 1991-02-01 | Applicant | |
| WO97/47231(A2) | 1997-12-01 | Applicant | |
| WO/12027 | 2000-03-01 | Applicant | |
| WO/32137 | 2000-06-01 | Applicant | |
| WO/78227 | 2000-12-01 | Applicant | |
| WO1/41671 | 2001-06-01 | Applicant | |
| WO1/45485 | 2001-06-01 | Applicant | |
| WO1/49359 | 2001-07-01 | Applicant | |
| WO1/66018 | 2001-09-01 | Applicant | |
| WO1/85034 | 2001-11-01 | Applicant | |
| WO1/89393 | 2001-11-01 | Applicant | |
| WO2/060328 | 2002-08-01 | Applicant | |
| WO3/017882 | 2003-03-01 | Applicant | |
| WO3/086246 | 2003-10-01 | Applicant | |
| WO3/086247 | 2003-10-01 | Applicant | |
| WO3/090633 | 2003-11-01 | Applicant | |
| WO3/094784 | 2003-11-01 | Applicant | |
| WO3/094785 | 2003-11-01 | Applicant | |
| WO3/099137 | 2003-12-01 | Applicant | |
| WO3/099137(A2) | 2003-12-01 | Applicant | |
| WO3105698(A2) | 2003-12-01 | Applicant | |
| WO2004/019765 | 2004-03-01 | Applicant | |
| WO2004/019787 | 2004-03-01 | Applicant | |
| WO2004/032760 | 2004-04-01 | Applicant | |
| WO2004/032760(A2) | 2004-04-01 | Applicant | |
| WO2004/037064 | 2004-05-01 | Applicant | |
| WO2004/041133 | 2004-05-01 | Applicant | |
| WO2004/064680 | 2004-08-01 | Applicant | |
| WO2004/064685 | 2004-08-01 | Applicant | |
| WO2004/080336 | 2004-09-01 | Applicant | |
| WO2004/110285 | 2004-12-01 | Applicant | |
| WO2004/110285(A1) | 2004-12-01 | Applicant | |
| WO2005/037152 | 2005-04-01 | Applicant | |
| WO2005/037152(A1) | 2005-04-01 | Applicant | |
| WO2005/079673 | 2005-09-01 | Applicant | |
| WO2005/079673(A2) | 2005-09-01 | Applicant | |
| WO2005/096991 | 2005-10-01 | Applicant | |
| WO2005/096991(A1) | 2005-10-01 | Applicant | |
| WO2005/105003 | 2005-11-01 | Applicant | |
| WO2006/016894 | 2006-02-01 | Applicant | |
| WO2006/016894(A1) | 2006-02-01 | Applicant | |
| WO2006/055365 | 2006-05-01 | Applicant | |
| WO2006/055365(A2) | 2006-05-01 | Applicant | |
| WO2006/127593 | 2006-11-01 | Applicant | |
| WO2007/041598 | 2007-04-01 | Applicant | |
| WO2007/041598(A1) | 2007-04-01 | Applicant | |
| WO2008/030403 | 2008-03-01 | Applicant | |
| WO2008/033409 | 2008-03-01 | Applicant | |
| WO2008/033474 | 2008-03-01 | Applicant | |
| WO2008/141288 | 2008-11-01 | Applicant | |
| WO2009/011881 | 2009-01-01 | Applicant | |
| WO2009/011882 | 2009-01-01 | Applicant | |
| WO2009/086549 | 2009-07-01 | Applicant | |
| WO2009/117533 | 2009-09-01 | Applicant | |
| WO2010/054399 | 2010-05-01 | Applicant | |
| WO2010/054404 | 2010-05-01 | Applicant |
Non-Patent Literature (25)
- International Search Report from PCT Patent Application No. PCT/US2002/027177 mailed Feb. 14, 2003.Applicant
- International Search Report from PCT Patent Application No. PCT/US2003/004378 mailed Aug. 13, 2003.Applicant
- International Search Report from PCT Patent Application No. PCT/US2003/033605 mailed Mar. 29, 2004.Applicant
- International Search Report from PCT Patent Application No. PCT/US2003/033606 mailed Mar. 29, 2004.Applicant
- International Search Report from PCT Patent Application No. PCT/US2003/004449 mailed Aug. 13, 2003.Applicant
- International Search Report from PCT Patent Application No. PCT/US2004/006695 mailed Sep. 8, 2004.Applicant
- International Search Report from PCT Patent Application No. PCT/US2004/033007 mailed Feb. 9, 2005.Applicant
- International Search Report from PCT Patent Application No. PCT/US2005/014372 mailed Jul. 28, 2005.Applicant
- International Search Report from PCT Patent Application No. PCT/US2006/019727 mailed Apr. 19, 2007.Applicant
- International Search Report from PCT Patent Application No. PCT/US2006/038684 mailed Feb. 14, 2007.Applicant
- International Search Report from PCT Patent Application No. PCT/US2007/019227 mailed Feb. 20, 2008.Applicant
- International Search Report from PCT Patent Application No. PCT/US2007/019833 mailed Feb. 20, 2008.Applicant
- International Search Report from PCT Patent Application No. PCT/US2007/019940 mailed Mar. 14, 2008.Applicant
- International Search Report from PCT Patent Application No. PCT/US2008/008726 mailed Oct. 16, 2008.Applicant
- International Search Report from PCT Patent Application No. PCT/US2008/008729 mailed Aug. 18, 2009.Applicant
- International Search Report from PCT Patent Application No. PCT/US2008/063440 mailed Aug. 1, 2008.Applicant
- International Search Report from PCT Patent Application No. PCT/US2008/088581 mailed Feb. 26, 2009.Applicant
- International Search Report from PCT Patent Application No. PCT/US2009/037586 mailed Sep. 28, 2009.Applicant
- International Search Report from PCT Patent Application No. PCT/US2009/063925 mailed Jan. 12, 2010.Applicant
- International Search Report from PCT Patent Application No. PCT/US2009/063930 mailed Jan. 12, 2010.Applicant
- Felsher, et al., “Mucosal apposition in endoscopic suturing”, Gastrointestinal Endoscopy, vol. 58, No. 6, pp. 867-870, (2003).Applicant
- Stecco, et al., “Trans-oral plication formation and gastric implant placement in a canine model”, Stecco Group, San Jose and Barosense, Inc., Redwood City, CA (2004).Applicant
- Stecco, et al. “Safety of a gastric restrictive implant in a canine model”, Stecco group, San Jose amd Barosense, Inc., Redwood City, CA (2004).Applicant
- Stecco, K. et al., “Trans-Oral Plication Formation and Gastric Implant Placement in a Canine Model”, Stecco Group, San Jose and Barosnese, Inc., Redwood City, California (2004).Applicant
- Stecco, K. et al., “Safety of a Gastric Restrictive Implant in a Canine Model”, Stecco Group, San Jose and Barosnese, Inc., Redwood City, California (2004).Applicant